
Sign up to save your podcasts
Or


December 8, 2025
FDA Approves Novel Blood-Based Assay to Stratify Prostate Cancer Biopsy Risk, Targeted Oncology
Researchers Define Unique, Soft Tissue Benign Tumor with Bony Shell That May Previously Have Been Mistaken as Malignant, Newswise
Navigating Visa Challenges Webinar
Donate to the CAP Foundation
Hosted on Ausha. See ausha.co/privacy-policy for more information.
By College of American Pathologists3.3
33 ratings
December 8, 2025
FDA Approves Novel Blood-Based Assay to Stratify Prostate Cancer Biopsy Risk, Targeted Oncology
Researchers Define Unique, Soft Tissue Benign Tumor with Bony Shell That May Previously Have Been Mistaken as Malignant, Newswise
Navigating Visa Challenges Webinar
Donate to the CAP Foundation
Hosted on Ausha. See ausha.co/privacy-policy for more information.

56,827 Listeners